$AEHR

SALAMONE ALBERTO sold $1.2M of AEHR

SALAMONE ALBERTO (EVP, PPBI BUSINESS) sold 9,672 shares of AEHR TEST SYSTEMS (AEHR) at an average of $127.72 ($127.50–$128.00, $1.24M total) across 2 trades on 2026-08-13.

Original reporting
SEC EDGAR · SALAMONE ALBERTO
Published Aug 14, 2026, 6:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 6:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not change AEHR fundamentals based on the provided text.

02

Market read

Traders may monitor whether this sale is part of broader insider selling, but there is no new guidance, contract, or regulatory development in the text.

03

What to watch

The absence of a disclosed 10b5-1 plan can raise scrutiny, but the article does not provide context on prior grants, option exercises, or total insider selling cadence.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-14 after-hours; transaction dated 2026-08-13

Background

This is an SEC Form 4 insider transaction disclosure for AEHR, reported by EVP Alberto Salamone.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR insider Form 4 shows EVP Alberto Salamone sold 9,672 shares in open-market trades for about $1.24M on 2026-08-13.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and limited unless follow-on selling accelerates.

Evidence & confidence

The filing is a primary-source Form 4, but it provides no new company-specific operational or financial information, and insider sales are often non-informational.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • AEHR

    AEHR Test Systems, the company whose insider transaction is disclosed.

  • Alberto Salamone

    EVP, PPBI Business, who sold 9,672 shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEHRMed

AEHR Stock Rides AI Order Wave Amid Volatility

Aehr Test Systems (AEHR) stock rose 13.28% following strong earnings and a positive outlook for semiconductor test demand. The company reported $50M in revenue, $18.8M in quarterly revenue, and a net income of $1.39M. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI production. The stock has shown volatility, with a recent drop of 9.5-10.5% in a single session. Insiders have sold shares but maintain significant holdings. AEHR is actively presenting a

$AEHRHigh

AEHR Stock Rallies As AI Orders And Wall Street Support Build

Aehr Test Systems (AEHR) stock rose 11.71% due to strong AI-related demand. The company reported $18.8M in revenue with a 35.3% gross margin. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's role in AI chip production. The company has a strong balance sheet and a $22M follow-on order from a major customer.

$AEHRHigh

AEHR Stock Rallies As AI Test Orders And Wall Street Support Grow

Aehr Test Systems (NASDAQ: AEHR) stock rose 11.73% on growing AI test demand. The company secured a $22M follow-on order for AI chip testing equipment. Jefferies initiated coverage with a Buy rating and $175 price target, citing AEHR's unique position in AI production testing. The stock has high volatility, with a strong balance sheet but negative EBIT margins.